BiotechTube
Home/AKIGAI/Morten Kompen
MK

Morten Kompen

Chief Financial Officer (CFO)

AKIGAI

Therapeutic Areas

NeurologyPain Management

AKIGAI Pipeline

DrugIndicationPhase
EGFR Inhibitor (Tyrosine Kinase Inhibitor - oral)Chronic Neuropathic PainPreclinical
EGFR Inhibitor (Monoclonal Antibody - parenteral)Chronic Neuropathic PainPreclinical
Modified/Targeted EGFR InhibitorChronic Neuropathic PainDiscovery

Leadership Team at AKIGAI

CK
Christian Kersten
MD PhD, Co-Founder, Clinical Oncologist, Researcher, Inventor
MC
Marte Cameron
MD PhD, Co-Founder, Clinical Oncologist, Researcher, Inventor
GS
Gry Stensrud
Chief Technical Officer (CTO) & Chief Organizational Officer (COO)
SN
Stig Nordal
LLM, MoM, MTM, Partner at DLA Piper's IPT Group, Advisor
GE
Gunnar Evensen
Board Member and Investor
GA
Gerard Akkerhuis
MD, Business Development Advisor
View full AKIGAI profile